Skip to search.
 TSX Up 2.88% TSX Ventures Up 3.00%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
130.89 Up 2.79(2.18%) 4:00PM EDT
Add to Portfolio
Prev Close:128.10
Open:129.50
Bid:128.70 x 200
Ask:134.99 x 1200
1y Target Est:160.35
Beta:1.09673
Earnings Date:Oct 21 - Oct 26 (Est.)
Day's Range:128.43 - 132.51
52wk Range:65.91 - 151.75
Volume:1,070,125
Avg Vol (3m):1,323,000
Market Cap:21.09B
P/E (ttm):N/A
EPS (ttm):-1.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BMRNUp 2.18%21.09B
FOLDUp 3.30%1.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.20
Quarterly EPS Est (Sep-15) :-0.65
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-2.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback